Because Ret and DJ-1 show convergence of their pro-survival activities, we suggest exploring the possibility that GDNF delivery might be most effective in PD patients carrying DJ-1 mutations, i.e. by activation of DJ-1 downstream signaling via Ret activation. This evidence concerns the gene RET and Parkinson disease.